Talphera, Inc.
General ticker "TLPH" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $19.6M (TTM average)
Talphera, Inc. follows the US Stock Market performance with the rate: 44.6%.
Estimated limits based on current volatility of 4.2%: low 1.07$, high 1.17$
Factors to consider:
- Total employees count: 13 as of 2024
- Current price 20.4% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.30$, 0.91$]
- 2025-12-31 to 2026-12-31 estimated range: [0.19$, 0.60$]
Financial Metrics affecting the TLPH estimates:
- Positive: with PPE of -1.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -85.19 <= 0.33
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 25.40 > -0.66
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
Short-term TLPH quotes
Long-term TLPH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.65MM | $0.00MM |
| Operating Expenses | $20.35MM | $17.54MM | $15.25MM |
| Operating Income | $-20.35MM | $-16.89MM | $-15.25MM |
| Non-Operating Income | $79.49MM | $6.60MM | $2.25MM |
| Interest Expense | $1.12MM | $0.13MM | $0.39MM |
| R&D Expense | $1.69MM | $5.55MM | $6.72MM |
| Income(Loss) | $59.14MM | $-10.29MM | $-13.00MM |
| Taxes | $0.01MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $42.52MM | $-18.40MM | $-13.00MM |
| Stockholders Equity | $21.81MM | $14.11MM | $8.00MM |
| Inventory | $1.18MM | $0.00MM | $0.00MM |
| Assets | $47.49MM | $20.39MM | $18.24MM |
| Operating Cash Flow | $-28.33MM | $-17.49MM | $-12.68MM |
| Capital expenditure | $0.36MM | $0.10MM | $0.00MM |
| Investing Cash Flow | $36.45MM | $-0.53MM | $3.78MM |
| Financing Cash Flow | $-0.51MM | $3.47MM | $12.04MM |
| Earnings Per Share** | $5.74 | $-1.29 | $-0.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.